EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Plasma Membrane: A Target and Hurdle for the Development of Anti- A? Drugs?

Patrice Talaga, Luc Quéré

Current Drug Target -CNS & Neurological Disorders · 2002

DOI: 10.2174/1568007023338897 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Target -CNS & Neurological Disorders, 2002. Verfasst von Patrice Talaga und 1 weiteren Autor:innen. Beteiligte Einrichtung: UCB S.A., Pharma Sector, Chemical Research, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium. patrice.talaga@ucb-group.com. Die Arbeit wurde bisher 13-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The plasma membrane has been the subject of intense investigation in the search for anti-amyloidogenic drugs for the treatment of Alzheimer's disease. Studies have highlighted numerous toxic properties of the well-known amyloid Abeta peptide on neuronal membranes. In this respect recent experimental data suggest that an early step in amyloid toxicity might be intracellularly mediated. This suggests that effective anti-amyloidogenic agents must be able to readily cross the plasma membrane while at the same time, counteracting the deleterious effects of the Abeta peptide on the phospholipid bilayer. This review summarizes recent findings regarding amyloid-plasma membrane interactions and discusses their relevance for the design of novel, potential anti-Abeta drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsCell MembraneDrug Delivery SystemsHumansTechnology, Pharmaceutical

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • UCB S.A., Pharma Sector, Chemical Research, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium. patrice.talaga@ucb-group.com

Zitieren

APA

Talaga, P., & Quéré, L. (2002). The Plasma Membrane: A Target and Hurdle for the Development of Anti- A? Drugs?. Current Drug Target -CNS & Neurological Disorders. https://doi.org/10.2174/1568007023338897

Vancouver

Talaga P, Quéré L. The Plasma Membrane: A Target and Hurdle for the Development of Anti- A? Drugs?. Current Drug Target -CNS & Neurological Disorders. 2002. doi:10.2174/1568007023338897

BibTeX
@article{Talaga2002,
  author = {Talaga, Patrice and Quéré, Luc},
  title = {The Plasma Membrane: A Target and Hurdle for the Development of Anti- A? Drugs?},
  journal = {Current Drug Target -CNS & Neurological Disorders},
  year = {2002},
  doi = {10.2174/1568007023338897}
}
Kostenlos starten →